BioSpace News Archive

Business

Intuitive Surgical Announces Preliminary Fourth Quarter and Full Year 2017 Results

Fourth quarter 2017 worldwide da Vinci procedures increased approximately 17% compared with the fourth quarter of 2016.

January 10, 2018
·
8 min read
Business

Easton Pharmaceuticals Announces the Appointment of Mr. Luigi Gentile as Director and Officer to the Company

Luigi brings to Easton Pharmaceuticals a broad history of commercial leadership and innovation experience leading sales, marketing, product management and R&D teams in Healthcare

January 10, 2018
·
4 min read
Biotech Bay

Marrone Bio Innovations Announces Availability of Next Generation Grandevo WDG Bioinsecticide in California

The industry recognizes NOW as the primary pest in pistachios and almonds.

January 10, 2018
·
5 min read
Business

PositiveID Announces 2017 Highlights and Projects Continued 30% Growth

Company expects year-over-year growth of over 30% for the 2017 fourth quarter and 2018 first quarter.

January 10, 2018
·
7 min read
Business

Accelerate Diagnostics Achieves CE-IVD Milestone for Severe Bacterial Pneumonia Assay, Doubles Revenue for 2017 in Q4

Revenue for the fourth quarter of 2017 of $2.1 million, a 52 times increase over the fourth quarter of 2016.

January 10, 2018
·
3 min read
Drug Development

Atara Biotherapeutics Announces FDA Clearance to Proceed With Enrollment at U.S. Sites for Ongoing Global Phase I Clinical Study to Evaluate ATA188 in Patients With Progressive or Relapsing-Remitting Multiple Sclerosis

The primary objective of Atara’s ongoing Phase 1 clinical study is to assess the safety of ATA188 in patients followed for at least one year after the first dose.

January 10, 2018
·
7 min read
Evogene Announces Positive 2nd Year Field Trial Results in Corn Bio-Stimulant Ag-Biologicals Program

Results demonstrated significant yield improvement; selected microbial strains to be tested as part of the collaboration with DuPont-Pioneer.

January 10, 2018
·
4 min read
FDA

Vertex Receives EU Approval for ORKAMBI (lumacaftor/ivacaftor) in Children with Cystic Fibrosis Ages 6-11 with Two Copies of the F508del Mutation

Vertex today announced that the European Commission has granted extension of the Marketing Authorization for ORKAMBI (lumacaftor/ivacaftor), the first medicine to treat the underlying cause of cystic fibrosis (CF) in people with two copies of the F508del mutation, to include children ages 6 through 11.

January 10, 2018
·
6 min read
BioCapital

Fluke Biomedical VT650 and VT900 Gas Flow Analyzers Offer the Highest Accuracy on the Market

Fluke Biomedical introduces the VT650 and VT900 Gas Flow Analyzers, which include one-channel, full-range air flow functionality that streamlines testing.

January 10, 2018
·
2 min read
Business

ANGLE plc: Notice of Results

ANGLE plc, a world-leading liquid biopsy company, will be releasing its interim results for the six months ended 31 October 2017 on Wednesday 31 January 2018.

January 10, 2018
·
4 min read